New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
According to a press release from the US Food and Drug Administration (FDA), on March 24, 2023, the agency issued a new draft guidance titled Clinical Trial Considerations to Support Accelerated…